文献速递老年慢病共病管理老年综合评估

年龄、多重慢性病与COVID-19:文献综述

Age, Multiple Chronic Conditions, and COVID-19: A Literature Review.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2022-01-01

该综述检索PubMed/MEDLINE并纳入28项研究,描述年龄和慢性病对COVID-19结局的预测作用。高血压、糖尿病、心血管病、慢性肺病和慢性肾病患病率范围宽,且各与院内病死率升高相关;老年患者病死率高于年轻患者(原文报告42%对65%)。

要点

  • 老年COVID-19患者病死率高于年轻患者(原文报告42%对65%)。
  • 高血压、糖尿病、心血管病、慢性肺病和慢性肾病均与院内病死率升高相关。
  • 仅1项研究按年龄分层分析慢性病与死亡风险,趋势在<65岁和>65岁相似。

核心结论

  • 年龄和慢性病对COVID-19结局有重要预测作用,但现有证据多采用单一慢性病 approach,需更全面评估多重共病负担和年龄的影响。

研究设计与样本

  • 文献综述,检索PubMed/MEDLINE并设置每日提醒,共纳入28项符合标准的研究。
  • 纳入研究样本量从21例到超过17,000,000例不等,参与者平均年龄48至80岁,男性比例44%至82%。

主要发现

  • COVID-19患者中最常见的基础疾病为高血压(范围15%-69%)、糖尿病(8%-40%)、心血管病(4%-61%)、慢性肺病(1%-33%)和慢性肾病(1%-48%)。
  • 上述每种基础疾病均与院内病死率升高相关,升高的病死率范围为1%至56%。
  • 老年COVID-19患者病死率高于年轻患者,原文报告<65岁为42%、>65岁为65%。
  • 仅1项研究分析了不同年龄组中慢性病与死亡风险的关联,发现<65岁和>65岁人群相比无这些疾病者风险升高的趋势相似。

临床怎么用

  • 接诊老年COVID-19患者时,应同时评估年龄和慢性病负担,而非仅关注单一疾病。

局限性

  • 现有研究多采用传统单一慢性病方法,缺乏对多重共病负担与年龄交互作用的完整评估。
  • 仅1项研究按年龄分层分析慢性病与死亡风险的关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Various patient demographic and clinical characteristics have been associated with poor outcomes for individuals with coronavirus disease 2019 (COVID-19). To describe the importance of age and chronic conditions in predicting COVID-19-related outcomes. METHODS: Search strategies were conducted in PubMed/MEDLINE. Daily alerts were created. RESULTS: A total of 28 studies met our inclusion criteria. Studies varied broadly in sample size (n = 21 to more than 17,000,000). Participants' mean age ranged from 48 years to 80 years, and the proportion of male participants ranged from 44% to 82%. The most prevalent underlying conditions in patients with COVID-19 were hypertension (range: 15%-69%), diabetes (8%-40%), cardiovascular disease (CVD) (4%-61%), chronic pulmonary disease (1%-33%), and chronic kidney disease (range 1%-48%). These conditions were each associated with an increased in-hospital case fatality rate (CFR) ranging from 1% to 56%. Overall, older adults have a substantially higher case fatality rate (CFR) as compared to younger individuals affected by COVID-19 (42% for those <65 vs 65% > 65 years). Only one study examined the association of chronic conditions and the risk of dying across different age groups; their findings suggested similar trends of increased risk in those < 65 years and those > 65 years as compared to those without these conditions. CONCLUSIONS: There has been a traditional, single-condition approach to consideration of how chronic conditions and advancing age relate to COVID-19 outcomes. A more complete picture of the impact of burden of multimorbidity and advancing patient age is needed.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Tisminetzky M, Delude C, Hebert T, et al. Age, Multiple Chronic Conditions, and COVID-19: A Literature Review. J Gerontol A Biol Sci Med Sci. 2022. PMID: 33367606. doi:10.1093/gerona/glaa320

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。